Sequential changes in plasma selenium concentration after cadaveric renal transplantation

British Journal of Surgery

Volumn 91, Issue 3, 2004, Pages 339-343

  Morris Stiff, G J ^a   Oleesky, D A ^b   Smith, S C ^b   Jurewicz, W A ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; METHYLPREDNISOLONE; PREDNISOLONE; SELENIUM; TACROLIMUS;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CADAVER DONOR; CHRONIC GRAFT NEPHROPATHY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADOLESCENT; ADULT; AGED; CADAVER; CYCLOSPORINE; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; SELENIUM; TACROLIMUS;

EID: 1642356719     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4427     Document Type: Article

References (26)

1. UK Transplant. Renal Transplant Audit 1990-1998. UK Transplant: Bristol, 2001.
2. Morris-Stiff GJ, Oleesky D, Jurewicz WA. Selenium deficiency: an important risk factor for chronic graft nephropathy. Transplantation 2003; 78: 1100-1104.
3. Stadtman TC. Selenium biochemistry - selected topics. Adv Inorg Biochem 1994; 10: 157-175.
4. Braganza JM. The pathogenesis of chronic pancreatitis. Q J Med 1979; 89: 243-250.
5. Foster LH, Sumar S. Selenium in health and disease: a review. Crit Rev Food Sci Nutr 1977; 37: 211-228.
6. Avissar N, Ornt DB, Yagil Y, Horowitz S, Watkins RH, Kerl EA et al. Human kidney proximal tubules are the main source of plasma glutathione peroxidase. Am J Physiol 1994; 266: C367-C375.
7. Whitin JC, Tham DM, Bhamre S, Ornt DB, Scandling JD, Tune BM et al. Plasma glutathione peroxidase and its relationship to renal proximal tubule function. Mol Genet Metab 1998; 65: 238-245.
8. Oster O, Prellwitz W. The renal excretion of selenium. Biol Trace Elem Res 1990; 24: 119-146.
9. Miller L, Mills BJ, Blotcky AJ, Lindeman RD. Red blood cell and serum selenium concentrations as influenced by age and selected diseases. J Am Coll Nutr 1983; 2: 331-341.
10. Kallistratos G, Evangelou A, Seferoadis K, Vezyraki P, Barboutis K. Selenium and haemodialysis: serum selenium levels in healthy persons, non-cancer and cancer patients with chronic renal failure. Nephron 1985; 41: 217-222.
11. Dworkin B, Weseley S, Rosenthal WS, Schwartz EM, Weiss L. Diminished blood selenium levels in renal failure patients on dialysis: correlation with nutritional status. Am J Med Sci 1987; 293: 6-12.
12. Girelli D, Olivieri O, Stanzial AM, Azzini M, Lupo A, Bernich P et al. Low platelet glutathione peroxidase activity and serum selenium concentration in patients with chronic renal failure: relations to dialysis treatments, diet and cardiovascular complications. Clin Sci (Lond) 1993; 84: 611-617.
13. Bonomini M, Manfrini V, Marini A, De Risio F, Niri L, Klinkmann H et al. Hemodialysis with regenerated cellulosic membranes does not reduce plasma selenium levels in chronic uremic patients. Artif Organs 1995; 19: 81-85.
14. Sriram K, Abraham G. Loss of zinc and selenium does not occur through peritoneal dialysis. Nutrition 2000; 16: 1047-1051.
15. Zachara BA, Trafikowska U, Adamowicz A, Nartowicz E, Manitius J. Selenium, glutathione peroxidases, and some other antioxidant parameters in blood of patients with chronic renal failure. J Trace Elem Med Biol 2001; 15: 161-166.
16. Apostolidis NS, Panoussopoulos DG, Stamou KM, Kekis PB, Paradellis TP, Karydas AG et al. Selenium metabolism in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 2002; 22: 400-404.
17. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411-422.
18. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
19. Humar A, Kerr S, Gillingham KJ, Matas AJ. Features of acute rejection that increase risk for chronic rejection. Transplantation 1999; 68: 1200-1203.
20. Inselmann G, Barth A, Engemann R, Heidemann HT. Cyclosporin-A-induced lipid peroxidation in human liver microsomes and its influence on cytochrome P-450. Eur J Clin Invest 1991; 21: 461-465.
21. Parra T, de Arriba G, Conejo JR, Cantero M, Arribas I, Rodriguez-Puyol D et al. Cyclosporine increases local gomerular synthesis of reactive oxygen species in rats: effect of vitamin E on cyclosporine nephrotoxicity. Transplantation 1998; 66: 1325-1329.
22. Wang C, Salahudeen AK. Lipid peroxidation accompanies cyclosporine nephrotoxicity: effects of vitamin E. Kidney Int 1995; 47: 927-934.
23. Apanay DC, Neylan JF, Ragab MS, Sgoutas DS. Cyclosporine increases the oxidizability of low-density lipoproteins in renal transplant recipients. Transplantation 1994; 58: 663-669.
24. Ghanem H, van den Dorpel MA, Weimar W, Man in 'T Veld AJ, El-Kannishy MH, Jansen H. Increased low density lipoprotein oxidation in stable renal transplant recipients. Kidney Int 1996; 49: 488-493.
25. Cristol JP, Vela C, Maggi MF, Descomps B, Mourard G. Oxidative stress and lipid abnormalities in renal transplant recipients with or without chronic rejection. Transplantation 1998; 65: 1322-1328.
26. Vela C, Cristol MF, Maggi MF, Ribstein J, Mimran A, Descomps B et al. Oxidative stress in renal transplant recipients with chronic rejection: rationale for antioxidant supplementation. Transplant Proc 1999; 31: 1310-1311.